Tonix Pharmaceuticals Holding Corp.TNXPNASDAQ
Loading
Year-over-year operating income growth rate
Percentile
P8
Near historical low
vs 2Y Ago
-15.8x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -46.02% |
| Q3 2025 | -16.86% |
| Q2 2025 | -76.26% |
| Q1 2025 | 28.59% |
| Q4 2024 | -44.53% |
| Q3 2024 | 15.28% |
| Q2 2024 | 14.01% |
| Q1 2024 | 21.87% |
| Q4 2023 | 2.91% |
| Q3 2023 | 2.95% |
| Q2 2023 | 14.45% |
| Q1 2023 | -3.59% |
| Q4 2022 | -10.60% |
| Q3 2022 | -26.80% |
| Q2 2022 | 11.73% |
| Q1 2022 | 10.32% |
| Q4 2021 | -59.05% |
| Q3 2021 | 21.34% |
| Q2 2021 | -13.63% |
| Q1 2021 | -21.81% |
| Q4 2020 | -41.87% |
| Q3 2020 | 15.45% |
| Q2 2020 | -94.49% |
| Q1 2020 | 16.45% |
| Q4 2019 | -10.68% |
| Q3 2019 | -33.61% |
| Q2 2019 | 6.21% |
| Q1 2019 | 17.69% |
| Q4 2018 | -38.06% |
| Q3 2018 | 9.80% |
| Q2 2018 | 12.09% |
| Q1 2018 | -26.07% |
| Q4 2017 | 5.00% |
| Q3 2017 | -21.01% |
| Q2 2017 | 5.28% |
| Q1 2017 | 32.21% |
| Q4 2016 | 1.30% |
| Q3 2016 | 22.64% |
| Q2 2016 | 29.81% |
| Q1 2016 | -4.57% |